Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 07, 2025 07:01 ET | Source: Research and Markets

Cholera Vaccines Industry Outlook, 2030: A $166.5 Million Landscape - Innovation and Global Vaccination Programs are Driving Expansion

Dublin, March 07, 2025 (GLOBE NEWSWIRE) -- The "Cholera Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
December 11, 2024 07:06 ET | Source: Research and Markets

Edible Vaccines Industry Outlook to 2028 & 2033: Worldwide Revenues Set to Reach $12.5 Billion by 2028

Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "Edible Vaccine Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The edible vaccine market size has grown strongly in...
August 30, 2024 04:05 ET | Source: Research and Markets

Global Cholera Vaccines Market - Global Inactivated Vaccine, Live Attenuated Vaccine, Injectable Vaccines, Oral Vaccines Forecast 2024-2030

Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Cholera Vaccines Market by Type (Inactivated Vaccine, Live Attenuated Vaccine), Method of Administration (Injectable Vaccines, Oral Vaccines),...
September 29, 2023 05:38 ET | Source: Research and Markets

Global Cholera Vaccines Market 2023-2028: Key Players Like Merck, Johnson & Johnson and Sanofi are Leading the Way in Research and Investment

Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The "Cholera Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
May 16, 2022 08:33 ET | Source: Research and Markets

Global Cholera Vaccines Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts

Dublin, May 16, 2022 (GLOBE NEWSWIRE) -- The "Cholera Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
June 04, 2019 16:05 ET | Source: Emergent BioSolutions

Emergent BioSolutions Announces FDA Approval of Change in Storage Conditions and Transfer of Manufacturing for Its Cholera Vaccine

GAITHERSBURG, Md., June 04, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced approval by the U.S. Food and Drug Administration (FDA) of the Prior Approval Supplement...